Cargando...
Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
INTRODUCTION: Nectin-4 is a tumor-associated antigen overexpressed in urothelial carcinoma and several other malignancies. It has emerged as a compelling target for novel tumor-directed therapies, particularly as a component of antibody-drug conjugates (ADCs), a growing class of anti-cancer therapeu...
Gardado en:
| Publicado en: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8224177/ https://ncbi.nlm.nih.gov/pubmed/34030536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2021.1929168 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|